<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04552938</url>
  </required_header>
  <id_info>
    <org_study_id>201800306B0</org_study_id>
    <nct_id>NCT04552938</nct_id>
  </id_info>
  <brief_title>LVA on Serum Profiling in Patients With Lymphedema</brief_title>
  <official_title>The Impact of Lymphaticovenous Anastomosis on Serum Profiling in Patients With Lymphedema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The correlation between oxidative stress and increased lymphedematous limb volume lacks&#xD;
      supporting evidence. Lymphedema patients are prone to cellulitis. This study aims to&#xD;
      investigate the link between oxidative stress, limb volume, and cellulitis after&#xD;
      supermicrosurgical lymphaticovenous anastomosis (LVA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we focused on the changes in serum antioxidant biomarkers before and after&#xD;
      LVA, detected by isobaric tags for relative and absolute quantitation (iTRAQ)-based&#xD;
      quantitative proteomic analysis, enzyme-linked immunosorbent assay (ELISA), and Oxidative&#xD;
      Stress Panel Kit. For clinical correlation, magnetic resonance (MR) volumetry was implemented&#xD;
      for precise lymphedematous limb volume measurements. Correlations were made between changes&#xD;
      in oxidative stress, limb volume, and cellulitis before and after LVA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 11, 2018</start_date>
  <completion_date type="Actual">September 11, 2020</completion_date>
  <primary_completion_date type="Actual">June 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the correlation between post-LVA volume reduction</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>The primary outcome was determined whether post-LVA volume reduction &lt; 40%</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>Patients underwent supermicrosurgical LVA</arm_group_label>
    <description>Patients underwent supermicrosurgical LVA between June 2018 and May 2019.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pre-LVA</intervention_name>
    <description>Venous serum samples were collected from patients before LVA.</description>
    <arm_group_label>Patients underwent supermicrosurgical LVA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>post-LVA</intervention_name>
    <description>Venous serum samples were collected from patients one-month after LVA.</description>
    <arm_group_label>Patients underwent supermicrosurgical LVA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Written informed consent was obtained from all patients. Between June 2018 and May 2019, 26&#xD;
        patients with lower limb lymphedema confirmed with lymphoscintigraphy were recruited.&#xD;
        Patients with upper limb and bilateral lower limb lymphedema were excluded.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with lower limb lymphedema confirmed with lymphoscintigraphy&#xD;
&#xD;
          -  unilateral lower limb lymphedema&#xD;
&#xD;
          -  lymphedema duration &gt; 2 years&#xD;
&#xD;
          -  no active infection&#xD;
&#xD;
          -  no prophylactic antibiotic use for at least one month before LVA&#xD;
&#xD;
          -  no tumor recurrence or metastasis&#xD;
&#xD;
          -  no consumption of antioxidants, such as vitamin E or ascorbic acid&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with upper limb and bilateral lower limb lymphedema&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>83301</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

